RiCHE Biotech

RiCHE Biotech was a Taiwan-based diagnostics and medical device company developing nucleic-acid amplification technology for rapid point-of-care molecular testing. The company originated from National Cheng Kung University and focused on its ATOM NAAT platform, described as a lysis-free photonic real-time PCR/qPCR-based assay system for frontline diagnostics. Publicly available information points to a business centered on molecular diagnostic instrumentation and assay systems rather than a therapeutic drug pipeline. Corporate registry data indicate the company was dissolved in November 2025, so it does not appear to be an active operating company as of April 2026.